These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 36215323)

  • 1. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
    PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Cameroon.
    Martinez-Vega R; Mbacham WF; Ali I; Nji A; Mousa A; Beshir KB; Chopo-Pizarro A; Kaur H; Okell L; Hansson H; Hocke EF; Alifrangis M; Gosling R; Roper C; Sutherland C; Chico RM
    BMC Infect Dis; 2024 Sep; 24(1):1028. PubMed ID: 39327613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
    Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G
    PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Barsosio HC; Madanitsa M; Ondieki ED; Dodd J; Onyango ED; Otieno K; Wang D; Hill J; Mwapasa V; Phiri KS; Maleta K; Taegtmeyer M; Kariuki S; Schmiegelow C; Gutman JR; Ter Kuile FO
    Lancet; 2024 Jan; 403(10424):365-378. PubMed ID: 38224710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial.
    Bigira V; Kapisi J; Clark TD; Kinara S; Mwangwa F; Muhindo MK; Osterbauer B; Aweeka FT; Huang L; Achan J; Havlir DV; Rosenthal PJ; Kamya MR; Dorsey G
    PLoS Med; 2014 Aug; 11(8):e1001689. PubMed ID: 25093754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
    Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
    BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.
    Mutabingwa TK; Muze K; Ord R; Briceño M; Greenwood BM; Drakeley C; Whitty CJ
    PLoS One; 2009; 4(4):e5138. PubMed ID: 19352498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
    Dicko A; Barry A; Dicko M; Diallo AI; Tembine I; Dicko Y; Dara N; Sidibe Y; Santara G; Conaré T; Chandramohan D; Cousens S; Milligan PJ; Diallo DA; Doumbo OK; Greenwood B
    PLoS One; 2011; 6(8):e23390. PubMed ID: 21858096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
    Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
    Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery effectiveness of and adherence to intermittent preventive treatment for malaria in pregnancy with dihydroartemisinin-piperaquine with or without targeted information transfer or sulfadoxine-pyrimethamine in western Kenya: a three-armed, pragmatic, open-label, cluster-randomised trial.
    Barsosio HC; Webster J; Omiti F; K'Oloo A; Odero IA; Ojuok MA; Odiwa D; Omondi B; Okello E; Dodd J; Taegtmeyer M; Kuile FOT; Lesosky M; Kariuki S; Hill J
    Lancet Glob Health; 2024 Oct; 12(10):e1660-e1672. PubMed ID: 39304238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monthly sulphadoxine-pyrimethamine combination versus daily proguanil for malaria chemoprophylaxis in sickle cell disease: a randomized controlled study at the Jos University Teaching Hospital.
    Dawam JA; Madaki JKA; Gambazai AA; Okpe ES; Lar-ndam N; Onu A; Gyang M
    Niger J Med; 2016; 25(2):119-27. PubMed ID: 29944308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali.
    Maiga H; Djimde AA; Beavogui AH; Toure O; Tekete M; Sangare CP; Dara A; Traore ZI; Traore OB; Dama S; N'Dong C; Niangaly H; Diallo N; Dembele D; Sagara I; Doumbo OK
    Malar J; 2015 Feb; 14():64. PubMed ID: 25889633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial.
    Nkosi-Gondwe T; Robberstad B; Opoka R; Kalibbala D; Rujumba J; Galileya LT; Akun P; Nambatya W; Ssenkusu J; TerKuile F; Phiri K; Idro R
    Trials; 2023 Apr; 24(1):257. PubMed ID: 37016392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.
    Bukirwa H; Critchley J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004966. PubMed ID: 16437507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
    Dicko A; Roh ME; Diawara H; Mahamar A; Soumare HM; Lanke K; Bradley J; Sanogo K; Kone DT; Diarra K; Keita S; Issiaka D; Traore SF; McCulloch C; Stone WJR; Hwang J; Müller O; Brown JM; Srinivasan V; Drakeley C; Gosling R; Chen I; Bousema T
    Lancet Infect Dis; 2018 Jun; 18(6):627-639. PubMed ID: 29422384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
    Cisse B; Cairns M; Faye E; NDiaye O; Faye B; Cames C; Cheng Y; NDiaye M; Lô AC; Simondon K; Trape JF; Faye O; NDiaye JL; Gaye O; Greenwood B; Milligan P
    PLoS One; 2009 Sep; 4(9):e7164. PubMed ID: 19784374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.
    Gutman J; Kovacs S; Dorsey G; Stergachis A; Ter Kuile FO
    Lancet Infect Dis; 2017 Feb; 17(2):184-193. PubMed ID: 27865890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
    Konaté AT; Yaro JB; Ouédraogo AZ; Diarra A; Gansané A; Soulama I; Kangoyé DT; Kaboré Y; Ouédraogo E; Ouédraogo A; Tiono AB; Ouédraogo IN; Chandramohan D; Cousens S; Milligan PJ; Sirima SB; Greenwood BM; Diallo DA
    PLoS One; 2011; 6(8):e23391. PubMed ID: 21858097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.